S&P 500

5.487,03

0,25%

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Cardiol Therapeutics Inc (CRDL)
Cardiol Therapeutics Inc (CRDL) Notícias

CRDL

Cardiol Therapeutics (CRDL)

Cardiol Therapeutics Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:CRDL

1

Data	Hora	Fonte	Título	Código	Companhia
13/06/2024	08:59	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CRDL	Cardiol Therapeutics Inc
15/02/2024	15:15	AllPennyStocks.com	Orphan Drug Designation Sends Shares of this Dual-Listed Life Science Therapy Company Soaring	NASDAQ:CRDL	Cardiol Therapeutics Inc
29/06/2023	12:45	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:CRDL	Cardiol Therapeutics Inc
29/03/2023	07:02	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:CRDL	Cardiol Therapeutics Inc
20/11/2022	05:35	TipRanks	Cardiol Therapeutics (CRDL) Receives a Rating Update from a Top Analyst	NASDAQ:CRDL	Cardiol Therapeutics Inc
20/11/2022	05:15	TipRanks	Canaccord Genuity Sticks to Their Buy Rating for Cardiol Therapeutics (CRDL)	NASDAQ:CRDL	Cardiol Therapeutics Inc
20/04/2022	17:50	Edgar (US Regulatory)	Amended Annual Report (foreign Private Issuer) (40-f/a)	NASDAQ:CRDL	Cardiol Therapeutics Inc
24/03/2022	07:07	Edgar (US Regulatory)	Annual Report (foreign Private Issuer) (40-f)	NASDAQ:CRDL	Cardiol Therapeutics Inc
08/02/2022	18:35	Edgar (US Regulatory)	Voluntary Supplemental Material Filed Pursuant to Section 11(a) of the Securities Act of 1933 by Foreign Issuers (suppl)	NASDAQ:CRDL	Cardiol Therapeutics Inc
08/02/2022	16:10	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement for Securities of Certain Canadian Issuers Under the Securities Act of 1933 (f-10pos)	NASDAQ:CRDL	Cardiol Therapeutics Inc
08/02/2022	15:53	Edgar (US Regulatory)	Amended Registration Statement for Securities of Certain Canadian Issuers Under the Securities Act of 1933 (f-10/a)	NASDAQ:CRDL	Cardiol Therapeutics Inc
07/02/2022	18:39	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CRDL	Cardiol Therapeutics Inc
26/01/2022	08:10	Edgar (US Regulatory)	Appointment of Agent for Service of Process and Undertaking (f-x)	NASDAQ:CRDL	Cardiol Therapeutics Inc
26/01/2022	08:01	Edgar (US Regulatory)	Registration Statement for Securities of Certain Canadian Issuers Under the Securities Act of 1933 (f-10)	NASDAQ:CRDL	Cardiol Therapeutics Inc
18/01/2022	18:23	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:CRDL	Cardiol Therapeutics Inc
18/01/2022	18:14	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:CRDL	Cardiol Therapeutics Inc
15/11/2021	12:42	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:CRDL	Cardiol Therapeutics Inc
03/11/2021	09:36	PR Newswire (Canada)	Cardiol Therapeutics Announces Pricing of Public Offering of Units	NASDAQ:CRDL	Cardiol Therapeutics Inc
02/11/2021	17:04	PR Newswire (Canada)	Cardiol Therapeutics Files Preliminary Prospectus Supplement for Proposed Public Offering of Units	NASDAQ:CRDL	Cardiol Therapeutics Inc